CATALOGO DEI PRODOTTI DELLA RICERCA

BELLUOMINI, Lorenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.063
AS - Asia 2.190
NA - Nord America 2.147
SA - Sud America 346
AF - Africa 94
OC - Oceania 14
Totale 7.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.059
RU - Federazione Russa 1.742
SG - Singapore 1.028
CN - Cina 384
IT - Italia 354
BR - Brasile 273
HK - Hong Kong 273
DE - Germania 246
VN - Vietnam 157
FI - Finlandia 131
FR - Francia 104
GB - Regno Unito 95
SE - Svezia 92
KR - Corea 89
IE - Irlanda 73
PL - Polonia 66
NL - Olanda 59
IN - India 57
CA - Canada 52
ID - Indonesia 37
JP - Giappone 37
TG - Togo 27
BJ - Benin 25
ES - Italia 25
MX - Messico 22
AR - Argentina 21
AT - Austria 20
TR - Turchia 20
CZ - Repubblica Ceca 16
EC - Ecuador 14
BD - Bangladesh 12
AU - Australia 11
ZA - Sudafrica 11
CO - Colombia 10
IR - Iran 10
VE - Venezuela 10
MA - Marocco 9
MY - Malesia 8
PK - Pakistan 8
BE - Belgio 7
LT - Lituania 7
TW - Taiwan 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CL - Cile 6
JO - Giordania 6
UZ - Uzbekistan 6
IQ - Iraq 5
SA - Arabia Saudita 5
UY - Uruguay 5
EG - Egitto 4
IL - Israele 4
KE - Kenya 4
PH - Filippine 4
UA - Ucraina 4
AO - Angola 3
BO - Bolivia 3
CH - Svizzera 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JM - Giamaica 2
KH - Cambogia 2
LV - Lettonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CY - Cipro 1
GD - Grenada 1
GT - Guatemala 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SD - Sudan 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 7.853
Salva come PNG Salva come JPEG
Città #
Moscow 617
Dallas 536
Singapore 483
Ashburn 287
Hong Kong 262
Chandler 155
Munich 154
The Dalles 89
Los Angeles 84
Helsinki 74
Beijing 73
Dublin 72
Verona 70
New York 60
Ho Chi Minh City 52
Milan 46
London 41
São Paulo 39
Meda 38
Redondo Beach 36
Tokyo 34
Buffalo 31
Turku 28
Warsaw 28
Hanoi 27
Lomé 27
Cotonou 25
Nuremberg 23
Santa Clara 23
Jakarta 22
Redmond 21
Lawrence 20
Princeton 20
Rome 20
Amsterdam 19
Columbus 18
Lappeenranta 18
Sindelfingen 18
Chicago 17
Seoul 17
Houston 16
Toronto 16
Brooklyn 15
Denver 15
Montreal 15
Atlanta 14
Frankfurt am Main 14
Orem 13
San Francisco 13
Seattle 13
Council Bluffs 12
Naples 12
Phoenix 12
Stockholm 12
Washington 12
Boardman 11
Boston 11
Chennai 11
Belo Horizonte 10
Brno 10
Da Nang 10
Falkenstein 10
Haiphong 10
Wilmington 10
Johannesburg 9
Tianjin 9
Vicenza 9
Vienna 9
Hyderabad 8
Mumbai 8
Ottawa 8
Porto Alegre 8
Querétaro 8
Rio de Janeiro 8
Trento 8
Biên Hòa 7
Brussels 7
Bursa 7
Chapel Hill 7
Jacksonville 7
Padova 7
Sydney 7
Amman 6
Baku 6
Bengaluru 6
Dongguan 6
Jinan 6
Jyväskylä 6
Kent 6
New Delhi 6
Poplar 6
Shanghai 6
Shenyang 6
Turin 6
Charlotte 5
Curitiba 5
Hangzhou 5
Isola della Scala 5
Krakow 5
Kuala Lumpur 5
Totale 4.264
Salva come PNG Salva come JPEG
Nome #
Exploring the Complex Interplay between Myeloid-Derived Suppressor Cells (MDSCs), Interleukins, and Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC) 274
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 274
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 165
A multimodal approach to cancer-related cachexia: from theory to practice 164
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 151
Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report 151
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode 149
A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study 148
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 143
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer 143
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done 141
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 141
Infections and Immunotherapy in Lung Cancer: A Bad Relationship? 134
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 133
Exercise for counteracting post-acute COVID-19 syndrome in patients with cancer: an old but gold strategy? 132
Exercise and anemia in cancer patients: could make the difference? 126
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 125
A qualitative study exploring the experiences and perspectives of patients with cancer attending a 12-week exercise program 121
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer 119
Exercise oncology: It is time to make a change 119
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 117
A cross-sectional study exploring the perception of exercise oncology in the Italian population 117
Effect of exercise on functional capacity in patients with advanced cancer: A meta-analysis of randomized controlled trials 117
Impact of exercise in patients with pancreatic cancer across different treatment phases: a systematic review 116
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions 112
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives 112
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 111
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 106
Feasibility of a novel exercise program for patients with breast cancer offering different modalities and based on patient preference 104
Implementation outcomes of early nutritional screening and referral for patients with thoracic cancers 101
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 100
Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancer 98
Nurses' perspectives on physical activity promotion in cancer patients: A qualitative research 98
Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study 97
Exercise and bone health in cancer: enemy or ally? 97
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories 97
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO) 95
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success 95
Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials 94
Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it 93
Exercise in men with prostate cancer: how to move on? 91
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 89
Combining a 9-month tailored physical exercise program with osimertinib and denosumab in a patient affected by advanced NSCLC with multiple osteolytic bone lesions: A case report 88
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 87
Drive the oncologists into exercise promotion in lung cancer 87
Study Design and Rationale for Espera Trial: A Multicentre, Randomized, Phase II Clinical Trial Evaluating the Potential Efficacy of Adding SBRT to Pembrolizumab-Pemetrexed Maintenance in Responsive or Stable Advanced Non-Squamous NSCLC After Chemo-Immunotherapy Induction 85
HER2 Aberrations in NSCLC: So Close Yet So Far 84
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study 82
Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study 81
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 81
Exploring the role of respiratory microbiome in lung cancer: A systematic review 80
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas 79
Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance 79
The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agents 78
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 78
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs 77
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy 74
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 74
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures 73
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study 72
Cardiac autonomic dysfunction in patients with cancer: exploring the role of physical exercise 71
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review 67
Overcome the Fear of Exercise in Patients With Bone Metastases: A Qualitative Study on Patients' Perception 67
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients 64
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed 61
Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors 61
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab 59
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 59
Physical activity guidelines in oncology: a systematic review of the current recommendations 57
Modern Challenges for Early-Phase Clinical Trial Design and Biomarker Discovery in Metastatic Non-Small-Cell Lung Cancer 57
Prognostic and predictive implications of tumor suppressor gene alterations in non-small cell lung cancer 56
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 54
Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates 54
Physical Exercise During Neoadjuvant Treatments for Non-Small Cell Lung Cancer: The Time is Coming 51
Meta-Analysis Exploring Tyrosine Kinase Inhibitor-Induced Weight Gain in Oncogene-Addicted NSCLC 48
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 46
Effect of exercise on bone-related outcomes in patients with cancer affected by bone metastases or bone loss: a systematic review and meta-analysis 42
How a physical exercise program performed by patients may impact caregiver burden in cancer: a qualitative study 40
Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke 40
Lung Cancer Screening: An Opportunity to Promote Physical Activity? 38
Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of Combination 37
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas 34
From supportive care to adjunctive treatment: the evolution in time of physical exercise and nutrition in lung cancer 34
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance 27
Totale 7.973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.481
article - articoli 29.951
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 530
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.962
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 4 4 8 12 16 9 0
2021/2022180 7 23 0 9 7 10 7 16 12 6 20 63
2022/2023463 22 50 40 93 26 111 1 25 49 12 25 9
2023/2024630 14 25 59 55 57 76 62 36 36 64 91 55
2024/20252.178 99 78 89 367 65 103 147 124 337 162 213 394
2025/20264.450 337 362 612 1.139 1.653 347 0 0 0 0 0 0
Totale 7.973